Huh, 65,149 patient aspirin prophylaxis study: 71% fewer cases [p=0.001] https://c19p.org/huh3
copied to clipboard
Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea
et al., medRxiv, doi:10.1101/2020.05.04.20089904 (Preprint)
Retrospective database analysis of 65,149 in South Korea, showing significantly lower cases with existing aspirin treatment. The journal version of this paper does not present the aspirin results (only combined results for NSAIDs).
|
risk of case, 71.0% lower, RR 0.29, p = 0.001, treatment 8 of 543 (1.5%), control 5,164 of 64,606 (8.0%), adjusted per study, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Huh et al., 4 May 2020, retrospective, database analysis, South Korea, preprint, 10 authors.
Contact:
eastside1st@gmail.com.
huh
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.